GlaxoSmithKline Pakistan Limited (GLAXO)

Appointment of Chief Financial Officer

Live Market Price

PKR 319.39

-6.62 (-2.03%)

AI Financial Summary & Key Takeaways

Automated extraction from official regulatory filing

Analyzed Sep 03, 09:39 AM

GLAXO announces the appointment of a new Chief Financial Officer.

This leadership change may impact future financial strategy and reporting.

No immediate financial impact or shareholder action is required.

Official company disclosure filed on Pakistan Stock Exchange

Document link not provided

Share this announcement with fellow investors:

Receive real-time WhatsApp & Android push notifications whenever GLAXO announces board meetings, dividend payouts, or moves in price.

Transmission of Quarterly Report for the Period Ended September 30, 2026

Financial Results for the Quarter Ended September 30, 2026

Board Meeting Quarter 3-2026

Shariah Disclosure for the Half Year ended June 30, 2026

Credit of Interim Cash Dividend

Appointment of Executive Director